Is there evidence that a cough caused by an angiotensin-converting-enzyme (ACE) inhibitor can develop after a year of therapy?

ACE Inhibitor-Induced Cough Can Develop After a Year of Therapy

Yes, ACE inhibitor-induced cough can absolutely develop months or even a year after starting therapy, and the ACE inhibitor should be discontinued regardless of when the cough begins. 1

Timing of Cough Onset

The ACCP evidence-based guidelines explicitly state that cough may occur within hours of the first dose OR its onset can be delayed for weeks to months after initiation of therapy 1. Research confirms that cough can emerge "not necessarily shortly after institution of therapy but months or even a year later" 2.

This delayed onset is a critical clinical pitfall—many physicians mistakenly assume that if a patient tolerates an ACE inhibitor for several months without cough, they are "safe" from this adverse effect. This is incorrect.

Key Clinical Recommendation

The ACCP guidelines (Grade B recommendation) are unequivocal: therapy with ACE inhibitors should be discontinued regardless of the temporal relation between the onset of cough and the initiation of ACE inhibitor therapy 1.

The diagnosis is confirmed when cough resolves within:

• 1-4 weeks in most patients after discontinuation
• Up to 3 months in a subgroup of patients 1

Incidence and Risk Factors

The actual incidence is 10-20% in clinical practice 2, 3, substantially higher than the 1.3% reported in drug labels 4. The cough occurs more commonly in:

• Women (significantly higher risk) 1, 3
• Nonsmokers 1
• Persons of Chinese origin 1

Management Algorithm

1. When cough develops at any time during ACE inhibitor therapy:

   • Discontinue the ACE inhibitor immediately
   • Do NOT switch to another ACE inhibitor—this is a class effect and cough will recur 2
   • Wait 1-4 weeks (up to 3 months) for resolution to confirm diagnosis

2. Alternative therapy:

   • Switch to an angiotensin receptor blocker (ARB), which has a cough incidence similar to placebo 1, 5
   • ARBs do not cause cough, even in patients with prior ACE inhibitor-induced cough 1

3. If compelling reason to retry ACE inhibitor:

   • After cough resolution, approximately 30% of patients will not develop cough on rechallenge 1
   • This should only be attempted if there is a strong clinical indication

Common Pitfall to Avoid

Do not dismiss a new cough in a patient on long-term ACE inhibitor therapy simply because they've been taking it for months or years without problems. The temporal relationship is irrelevant—ACE inhibitors can sensitize the cough reflex over time through bradykinin and substance P accumulation 1. Always consider the ACE inhibitor as causative and perform a trial discontinuation.